1084 logo

Green Fresh Biotechnology Stock Price

Symbol: SEHK:1084Market Cap: HK$629.4mCategory: Materials

1084 Share Price Performance

Community Fair Values

    Recent 1084 News & Updates

    No updates

    Green Fresh Biotechnology Company Limited Key Details

    CN¥989.3m

    Revenue

    CN¥766.8m

    Cost of Revenue

    CN¥222.5m

    Gross Profit

    CN¥160.3m

    Other Expenses

    CN¥62.2m

    Earnings

    Last Reported Earnings
    Dec 31, 2024
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    0.071
    Gross Margin
    22.49%
    Net Profit Margin
    6.28%
    Debt/Equity Ratio
    66.1%

    Green Fresh Biotechnology Company Limited Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 1084

    Founded
    2001
    Employees
    1148
    CEO
    Kam Chung Chan
    WebsiteView website
    www.greenfreshfood.com

    Green Fresh Biotechnology Company Limited, an investment holding company, produces and sells seaweed-based and plant-based hydrocolloid products in China, Europe, rest of Asia, South America, North America, Africa, and Oceania. It operates through five segments: Manufacturing and Sales of Agar-Agar; Manufacturing and Sales of Carrageenan; Manufacturing and Sales of Konjac Products; Manufacturing and Sales of Blended Products; and Others. The company offers hydrocolloid products, including carrageenan, agar agar, and konjac gum and flour. It is also involved in trading of milk powder. The company’s products are used in soft candy, jelly/pudding, meat product, plant-based meat product, jam, ice-cream, drinks, pet foods, yokan, popping beads, pearls beads, blackcurrant sauce bun, and pulp jam solution applications. The company was formerly known as Green Future Food Hydrocolloid Marine Science Company Limited and changed its name to Green Fresh Biotechnology Company Limited in July 2025. Green Fresh Biotechnology Company Limited was founded in 2001 and is headquartered in North Point, Hong Kong.

    Hong Kong Market Performance

    • 7 Days: -0.1%
    • 3 Months: 18.2%
    • 1 Year: 41.4%
    • Year to Date: 29.3%
    The Healthcare sector gained 8.0% while the market remained flat over the last week. Meanwhile, the market is actually up 41% over the past year. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading